West Michigan Advisors »

Alnylam Pharmaceuticals shares owned by West Michigan Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by West Michigan Advisors from 13F filings

Historical chart of West Michigan Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by West Michigan Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by West Michigan Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5M 5.4k 456.00

More positions owned by West Michigan Advisors

Gentex Corp Common Stock (GNTX)
Amplify CWP Enhanced DIV Inm ETF Etf (DIVO)
Microsoft Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Innovator US Eqy Power Buffer ETF Etf (PSEP)
Broadcom Common Stock (AVGO)
Vanguard S&P 500 ETF Etf (VOO)
JPMorgan Chase Common Stock (JPM)
Huntington Banc Common Stock (HBAN)
J P Morgan Nasdaq EQT PRM Inc ETF IV Etf (JEPQ)
Capital Group Global GRWT Eqy ETF Etf (CGGO)
Amazon.Com Common Stock (AMZN)
Newmont Corp Common Stock (NEM)
Apple Common Stock

View all positions for West Michigan Advisors

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals